Immutep (IMMP) Non-Current Debt (2014 - 2015)

Immutep's (IMMP) quarterly Non-Current Debt came in at $1.2 million in Q2 2015, down 99.95% on a QoQ basis from $2.4 billion in Q4 2014.

Immutep (IMMP) Non-Current Debt (2014 - 2015) Analysis & Trends

Immutep (IMMP) has 2 years of Non-Current Debt data on file, last reported at $1.2 million in Q2 2015.

Quarterly Non-Current Debt changed N/A year-over-year to $1.2 million in Q2 2015, while the trailing twelve-month figure through Jun 2015 was $1.2 million (changed N/A YoY) and the FY2015 annual result came in at $1.2 million, changed N/A from the prior year.
Non-Current Debt eased to $1.2 million in Q2 2015, from $2.4 billion in the prior quarter.
In the past five years, Non-Current Debt ranged from a high of $2.4 billion in Q4 2014 to a low of $1.2 million in Q2 2015.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Non-Current Debt (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn	1.99 Bn
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn	-
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn	591.00 Mn
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn	882.16 Mn
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn	-
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn	546.77 Mn
8	Royalty Pharma	26.98 Bn	26.14 Bn	-	8.96 Bn
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn	360.97 Mn
10	Immutep	57.14 Mn	-7.95 Mn	-	-

Download Data

Date	Value
Jun 30, 2015	1.17 Mn
Dec 31, 2014	2.42 Bn